45 multiple-sequence-alignment positions at University of Newcastle in United Kingdom
Sort by
Refine Your Search
-
-ordinate complex projects across multiple research teams Extensive experience of working with mouse models of liver fibrosis and liver cancer Excellent skills in flow cytometry, imaging mass cytometry (IMC
-
and content delivery using best practice. Ability to effectively communicate our brand standards through content design. Outstanding organisational skills with the ability to manage multiple projects
-
, please upload your CV and cover letter evidencing how your skills and experiences align to the person specification as outlined in the job description. For informal enquiries, please contact Steph
-
To work closely with colleagues/teams at School, University and faculty level to: deliver Business School strategy, ensuring alignment with the University’s strategies, policies, guidelines and approaches
-
/teams at School, University and faculty level to: deliver Business School strategy, ensuring alignment with the University’s strategies, policies, guidelines and approaches; share best practice in a
-
and interpretation of results Supporting the analysis of multiple mitochondrial ‘omics datasets, such genomics, transcriptomics and clinical data Collaborating regularly with the team members and
-
activities aligned with Shipping and Logistics Deliver high-quality teaching across undergraduate and postgraduate programmes, developing innovative teaching materials supporting Marine Technology Supervise
-
best practice Ability to effectively communicate our brand standards through content design Outstanding organisational skills with the ability to manage multiple projects at same time Able to identify
-
at School, University and Faculty level to deliver on the Business School strategy, ensuring alignment with the University’s strategies, policies, guidelines and approaches; share best practice in a service
-
. The RELMED study is currently in the set-up phase. It consists of two randomised clinical trials to be run in sequence. The first trial will start early 2025 to 2027. This will be followed by a second trial to